|
Expression of AMACR in HCC, HCA, CN and NLT |
|||||
| AMACR staining intensity* n (%) |
|||||
|
|
|||||
| Low expression |
High expression |
||||
|
|
|
||||
| 0 |
1+ |
2+ |
3+ |
Total No. of Cases |
|
|
|
|||||
| HCC |
0(0) |
9(18) |
16(31) |
26(51) |
51 |
| WDHCC |
0(0) |
2 (14) |
5 (36) |
7 (50) |
14 |
| MDHCC |
0(0) |
4 (18) |
6 (27) |
12 (55) |
22 |
| PDHCC |
0(0) |
3 (20) |
5 (33) |
7 (47) |
15 |
| HCA |
6(67) |
2 (22) |
1 (11) |
0 (0) |
9 |
| CN |
16 (33) |
26 (54) |
6 (13) |
0 (0) |
48 |
| NLT |
13(81) |
2(13) |
1(6) |
0(0) |
16 |
|
Note: WDHCC indicates well differentiated HCC;MDHCC: moderately differentiated HCC;PDHCC: poorly differentiated HCC; HCA: Hepatocellular adenoma; CN: Cirrhotic nodules, NLT: normal liver tissue *Staining intensity is graded as 0 (scant faint finely granular background staining), 1+ (weak), 2+ (moderate), or 3+ (strong). | |||||
Li et al. Journal of Experimental & Clinical Cancer Research 2008 27:2 doi:10.1186/1756-9966-27-2 |
|||||